The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
These 7 mutual funds held over Rs 5,000 crore cash in March
The largest fund house by assets managed was sitting on Rs 23,384.81 crore cash in March.
April 16, 2024